A citation-based method for searching scientific literature

Xiaohong Xu, Yilin Tay, Bernice Sim, Su-In Yoon, Yihui Huang, Jolene Ooi, Kagistia Hana Utami, Amin Ziaei, Bryan Ng, Carola Radulescu, Donovan Low, Alvin Yu Jin Ng, Marie Loh, Byrappa Venkatesh, Florent Ginhoux, George J Augustine, Mahmoud A Pouladi. Stem Cell Reports 2017
Times Cited: 126







List of co-cited articles
1665 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
Mahru C An, Ningzhe Zhang, Gary Scott, Daniel Montoro, Tobias Wittkop, Sean Mooney, Simon Melov, Lisa M Ellerby. Cell Stem Cell 2012
250
32

Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki, Megumi Narita, Tomoko Ichisaka, Kiichiro Tomoda, Shinya Yamanaka. Cell 2007
28



CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.
Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
166
26

Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
Jun Wan Shin, Kyung-Hee Kim, Michael J Chao, Ranjit S Atwal, Tammy Gillis, Marcy E MacDonald, James F Gusella, Jong-Min Lee. Hum Mol Genet 2016
144
25

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
24


CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.
Su Yang, Renbao Chang, Huiming Yang, Ting Zhao, Yan Hong, Ha Eun Kong, Xiaobo Sun, Zhaohui Qin, Peng Jin, Shihua Li,[...]. J Clin Invest 2017
180
21

Multiplex genome engineering using CRISPR/Cas systems.
Le Cong, F Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D Hsu, Xuebing Wu, Wenyan Jiang, Luciano A Marraffini,[...]. Science 2013
20

Embryonic stem cell lines derived from human blastocysts.
J A Thomson, J Itskovitz-Eldor, S S Shapiro, M A Waknitz, J J Swiergiel, V S Marshall, J M Jones. Science 1998
18


Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.
Jolene Ooi, Sarah R Langley, Xiaohong Xu, Kagistia H Utami, Bernice Sim, Yihui Huang, Nathan P Harmston, Yi Lin Tay, Amin Ziaei, Ruizhu Zeng,[...]. Cell Rep 2019
36
50

Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.
Ningzhe Zhang, Mahru C An, Daniel Montoro, Lisa M Ellerby. PLoS Curr 2010
181
17

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.
Stefano Camnasio, Alessia Delli Carri, Angelo Lombardo, Iwona Grad, Caterina Mariotti, Alessia Castucci, Björn Rozell, Pietro Lo Riso, Valentina Castiglioni, Chiara Zuccato,[...]. Neurobiol Dis 2012
130
15

Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
Evgeny D Nekrasov, Vladimir A Vigont, Sergey A Klyushnikov, Olga S Lebedeva, Ekaterina M Vassina, Alexandra N Bogomazova, Ilya V Chestkov, Tatiana A Semashko, Elena Kiseleva, Lyubov A Suldina,[...]. Mol Neurodegener 2016
89
16

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
F Ann Ran, Patrick D Hsu, Chie-Yu Lin, Jonathan S Gootenberg, Silvana Konermann, Alexandro E Trevino, David A Scott, Azusa Inoue, Shogo Matoba, Yi Zhang,[...]. Cell 2013
14

Genome engineering using the CRISPR-Cas9 system.
F Ann Ran, Patrick D Hsu, Jason Wright, Vineeta Agarwala, David A Scott, Feng Zhang. Nat Protoc 2013
14

Cerebral organoids model human brain development and microcephaly.
Madeline A Lancaster, Magdalena Renner, Carol-Anne Martin, Daniel Wenzel, Louise S Bicknell, Matthew E Hurles, Tessa Homfray, Josef M Penninger, Andrew P Jackson, Juergen A Knoblich. Nature 2013
14

RNA-guided human genome engineering via Cas9.
Prashant Mali, Luhan Yang, Kevin M Esvelt, John Aach, Marc Guell, James E DiCarlo, Julie E Norville, George M Church. Science 2013
14

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.
Stuart M Chambers, Christopher A Fasano, Eirini P Papapetrou, Mark Tomishima, Michel Sadelain, Lorenz Studer. Nat Biotechnol 2009
14

Induced pluripotent stem cell lines derived from human somatic cells.
Junying Yu, Maxim A Vodyanik, Kim Smuga-Otto, Jessica Antosiewicz-Bourget, Jennifer L Frane, Shulan Tian, Jeff Nie, Gudrun A Jonsdottir, Victor Ruotti, Ron Stewart,[...]. Science 2007
14

Polyglutamine Disease Modeling: Epitope Based Screen for Homologous Recombination using CRISPR/Cas9 System.
Mahru C An, Robert N O'Brien, Ningzhe Zhang, Biranchi N Patra, Michael De La Cruz, Animesh Ray, Lisa M Ellerby. PLoS Curr 2014
52
26

Disease-specific induced pluripotent stem cells.
In-Hyun Park, Natasha Arora, Hongguang Huo, Nimet Maherali, Tim Ahfeldt, Akiko Shimamura, M William Lensch, Chad Cowan, Konrad Hochedlinger, George Q Daley. Cell 2008
14

Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
Iksoo Jeon, Nayeon Lee, Jia-Yi Li, In-Hyun Park, Kyoung Sun Park, Jisook Moon, Sung Han Shim, Chunggab Choi, Da-Jeong Chang, Jihye Kwon,[...]. Stem Cells 2012
137
13

Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases.
Magdalena Dabrowska, Wojciech Juzwa, Wlodzimierz J Krzyzosiak, Marta Olejniczak. Front Neurosci 2018
56
23

Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes.
Matheus B Victor, Michelle Richner, Hannah E Olsen, Seong Won Lee, Alejandro M Monteys, Chunyu Ma, Christine J Huh, Bo Zhang, Beverly L Davidson, X William Yang,[...]. Nat Neurosci 2018
114
13

Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.
P Conforti, D Besusso, V D Bocchi, A Faedo, E Cesana, G Rossetti, V Ranzani, C N Svendsen, L M Thompson, M Toselli,[...]. Proc Natl Acad Sci U S A 2018
86
15

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
653
12

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
418
12

Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Jung-Il Chae, Dong-Wook Kim, Nayeon Lee, Young-Joo Jeon, Iksoo Jeon, Jihye Kwon, Jumi Kim, Yunjo Soh, Dong-Seok Lee, Kang Seok Seo,[...]. Biochem J 2012
73
16

Role of brain-derived neurotrophic factor in Huntington's disease.
Chiara Zuccato, Elena Cattaneo. Prog Neurobiol 2007
393
12

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
Alexis C Komor, Yongjoo B Kim, Michael S Packer, John A Zuris, David R Liu. Nature 2016
11

CRISPR provides acquired resistance against viruses in prokaryotes.
Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau, Melissa Richards, Patrick Boyaval, Sylvain Moineau, Dennis A Romero, Philippe Horvath. Science 2007
11

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.
Thomas Gaj, Charles A Gersbach, Carlos F Barbas. Trends Biotechnol 2013
11

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
Mason A Israel, Shauna H Yuan, Cedric Bardy, Sol M Reyna, Yangling Mu, Cheryl Herrera, Michael P Hefferan, Sebastiaan Van Gorp, Kristopher L Nazor, Francesca S Boscolo,[...]. Nature 2012
788
11

Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
Frank Soldner, Yonatan Stelzer, Chikdu S Shivalila, Brian J Abraham, Jeanne C Latourelle, M Inmaculada Barrasa, Johanna Goldmann, Richard H Myers, Richard A Young, Rudolf Jaenisch. Nature 2016
334
10

Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
Chul-Yong Park, Tomer Halevy, Dongjin R Lee, Jin Jea Sung, Jae Souk Lee, Ofra Yanuka, Nissim Benvenisty, Dong-Wook Kim. Cell Rep 2015
113
10

Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.
Feng-Lan Chiu, Jun-Tasi Lin, Ching-Yu Chuang, Ting Chien, Chiung-Mei Chen, Kai-Hsiang Chen, Han-Yun Hsiao, Yow-Sien Lin, Yijuang Chern, Hung-Chih Kuo. Hum Mol Genet 2015
45
22

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
Nivya Kolli, Ming Lu, Panchanan Maiti, Julien Rossignol, Gray L Dunbar. Int J Mol Sci 2017
41
24

Molecular mechanisms and potential therapeutical targets in Huntington's disease.
Chiara Zuccato, Marta Valenza, Elena Cattaneo. Physiol Rev 2010
572
10

HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity.
Virginia B Mattis, Colton Tom, Sergey Akimov, Jasmine Saeedian, Michael E Østergaard, Amber L Southwell, Crystal N Doty, Loren Ornelas, Anais Sahabian, Lindsay Lenaeus,[...]. Hum Mol Genet 2015
77
12


Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.
Bernd Zetsche, Jonathan S Gootenberg, Omar O Abudayyeh, Ian M Slaymaker, Kira S Makarova, Patrick Essletzbichler, Sara E Volz, Julia Joung, John van der Oost, Aviv Regev,[...]. Cell 2015
9

Human iPSC-based modeling of late-onset disease via progerin-induced aging.
Justine D Miller, Yosif M Ganat, Sarah Kishinevsky, Robert L Bowman, Becky Liu, Edmund Y Tu, Pankaj K Mandal, Elsa Vera, Jae-won Shim, Sonja Kriks,[...]. Cell Stem Cell 2013
442
9

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.
Xing Guo, Marie-Helene Disatnik, Marie Monbureau, Mehrdad Shamloo, Daria Mochly-Rosen, Xin Qi. J Clin Invest 2013
232
9

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.
Ha Nam Nguyen, Blake Byers, Branden Cord, Aleksandr Shcheglovitov, James Byrne, Prachi Gujar, Kehkooi Kee, Birgitt Schüle, Ricardo E Dolmetsch, William Langston,[...]. Cell Stem Cell 2011
513
9

Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.
Karen L Ring, Mahru C An, Ningzhe Zhang, Robert N O'Brien, Eliana Marisa Ramos, Fuying Gao, Robert Atwood, Barbara J Bailus, Simon Melov, Sean D Mooney,[...]. Stem Cell Reports 2015
62
14

Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector.
Chengzhong Wang, Ramsey Najm, Qin Xu, Dah-Eun Jeong, David Walker, Maureen E Balestra, Seo Yeon Yoon, Heidi Yuan, Gang Li, Zachary A Miller,[...]. Nat Med 2018
166
9

CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Shuming Ouyang, Yingjun Xie, Zeyu Xiong, Yi Yang, Yexing Xian, Zhanhui Ou, Bing Song, Yuchang Chen, Yuhuan Xie, Haoxian Li,[...]. Stem Cells Dev 2018
36
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.